SCHEMBL7787864

SCHEMBL7787864

COCCOc1ccc(C=O)c(OC)c1OCCOC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.45
ALDH1A1 P00352 5/20 0.44
HPGD P15428 3/20 0.44
HTT P42858 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
TUBB1 Q9H4B7 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
EGFR P00533 4/20 0.39
TNFRSF1A P19438 1/20 0.38
SRC P12931 1/20 0.38
MAPT P10636 3/20 0.38
LMNA P02545 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15051368 0.89 ALDH1A1 (0.43) FDPSALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL8377299 0.84 ALDH1A1 (0.58) FDPSALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL28875403 0.82 ALDH1A1 (0.59) FDPSALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL30663744 0.82 ALDH1A1 (0.59) FDPSALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL28075459 0.81 L3MBTL1 (0.46) FDPSALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL8381920 0.81 TNFRSF1A (0.47) FDPSALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL5452274 0.80 EGFR (0.41) FDPSALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL4725328 0.80 ALDH1A1 (0.47) FDPSALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL1536736 0.78 ALDH1A1 (0.54) ALDH1A1HPGDHTTSMN1; SMN2NPC1
SCHEMBL8636872 0.78 LMNA (0.46) ALDH1A1TUBB1CA1CA2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0761672-B1 Cephalosporins containing in position 7 a substituted benzyloxyimino radical, processes for their preparation and intermediates for their preparation, their use as medicaments AVENTIS PHARMA SA (FR) 2001-11-07 EP disclosed
US-5710147-A ANTIBIOTICS ROUSSEL UCLAF (FR) 1998-01-20 US disclosed
EP-0761672-A1 Cephalosporin containing in position 7 a substituted benzyloxyimino radical, processes for their preparation and intermediates for their preparation, their use as medicaments ROUSSEL UCLAF (FR) 1997-03-12 EP disclosed